Study of IBR733 Cell Injection in Acute Myeloid Leukemia

Clinical trial NCT06234904 · RECRUITING

Trial details

NCT number: NCT06234904
Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-03-26
Primary completion: 2027-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.